Other reports suggest that naringenin (10 μM) induces apoptosis via the p38/MAPK pathway, which is modulated by ERβ agonist activation in DLD-1 colon cancer cells [40,41]. This evidence concerns the gene ESR2 and malignant colon neoplasm.